The Food and Drug Administration (FDA) has approved Zusduri (mitomycin intravesical solution) for adults with recurrent low-grade intermediate-risk non-muscle invasive bladder cancer (NMIBC).

Pembrolizumab significantly reduced the risk of event free survival events by 30% compared with standard of care.

In real-world cohort, percentage weight reduction at one year was 3.6, 6.8, and 11.9% with early and late discontinuation and nondiscontinuation, respectively.

HealthDay News — For critically ill adults with sepsis, statin use is associated with reduced mortality, according to a study published online June 5 in Frontiers in Immunology.

A longtime vaccine critic hired by Health Secretary Robert F. Kennedy Jr. is reviewing safety data in an effort to revisit debunked claims that vaccines may cause autism.

In an average-risk colorectal cancer screening population, a blood-based circulating tumor DNA test is feasible.

Some FDA staff said Elsa often gave wrong answers, what experts call “hallucinations”, and has to be double-checked.

The US Department of Health and Human Services (HHS) Secretary Robert F. Kennedy Jr named 8 new members to the Centers for Disease Control and Prevention (CDC)’s Advisory Committee on Immunization ...

Widaplik is indicated for the treatment of hypertension, including as initial treatment, to lower blood pressure.

HealthDay News — A healthy diet improves cardiometabolic risk factors, even if not associated with weight loss (WL), according to a study published online June 5 in the European Journal of Preventive ...

The approval was based on two phase 1 crossover studies, which compared zanubrutinib tablets with the capsule formulation in healthy adult participants.

HealthDay News — Mailed self-collection (SC) kits may increase participation in cervical cancer screening, according to a study published online June 6 in JAMA Internal Medicine.